Phase 1 × Adenocarcinoma, Bronchiolo-Alveolar × Clear all Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed
Phase 1 Completed
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 1 Completed
17 enrolled 12 charts
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Phase 1 Completed
11 enrolled
Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status
Phase 1 Completed
60 enrolled
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
Phase 1 Completed
18 enrolled
Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 1 Completed
45 enrolled
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction
Phase 1 Completed
39 enrolled
Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery
Phase 1 Completed
Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
Phase 1 Terminated
36 enrolled
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
18 enrolled
Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases
Phase 1 Completed
Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer
Phase 1 Completed
Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer
Phase 1 Terminated
48 enrolled
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Completed
18 enrolled